Non-steroidal anti-inflammatory drugs and small cell lung cancer risk in the VITAL study

Theodore M. Brasky, Christina S. Baik, Christopher G. Slatore, John D. Potter, Emily White

Research output: Contribution to journalArticle

10 Scopus citations


Few studies have examined the association between non-steroidal anti-inflammatory drug (NSAID) use and risk of small cell lung cancer (SCLC); among them, findings are mixed. Recently, we found that use of NSAIDs was differentially associated with lung cancer risk by histology. Here, we examine, more comprehensively, the association between individual NSAIDs and SCLC risk. 75,546 residents of western Washington State, ages 50-76, completed a baseline questionnaire in 2000-2002 and reported on their use of individual NSAIDs over the past 10 years. NSAID use was categorized as non-users, low (

Original languageEnglish (US)
Pages (from-to)260-264
Number of pages5
JournalLung Cancer
Issue number2
Publication statusPublished - Aug 2012



  • Aspirin
  • Ibuprofen
  • Small cell lung cancer

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this